Stonepine Capital Management, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2023$4,642,058
-28.4%
448,508
-36.1%
1.67%
-23.0%
Q1 2023$6,482,183
-44.0%
701,535
-46.2%
2.17%
-55.4%
Q4 2022$11,574,880
+23.7%
1,304,947
+16.1%
4.87%
+15.8%
Q3 2022$9,354,000
+2.8%
1,124,220
+1.2%
4.20%
-0.7%
Q2 2022$9,099,000
+288.5%
1,111,050
+313.3%
4.23%
+335.9%
Q1 2022$2,342,000268,8330.97%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders